Welcome to CDC Stacks | Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma - authors’ reply - 42169 | CDC Public Access | Arctic Investigations Program
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma - authors’ reply
Filetype[PDF - 30.37 KB]


Details:
No Related Documents.
You May Also Like:
  1. Nested Case-Control Study: Hepatocellular Carcinoma Risk After Hepatitis B Surface Antigen Seroclearance
    Personal Author:
    Gounder, Prabhu P.; Bulkow, Lisa R.; Snowball, Mary; Negus, Susan; Spradling, Philip R.; Simons, Brenna C.; McMahon, Brian J.;
    Published:
    Apr 08 2016
    Source:
    Aliment Pharmacol Ther. 43(11):1197-1207.
    Description:
    Background : Hepatocellular carcinoma (HCC) risk after resolving chronic hepatitis B virus (HBV) infection is unclear. : Aim : To compare HCC risk between Alaska Native (AN) patients with and without hepatitis B surface antigen (HBsAg) seroclearance....
    File Type:
    Filetype[PDF - 374.54 KB]
  2. Coming Soon
    Incidence of Hepatocellular Carcinoma According to Hepatitis B Virus Genotype in Alaska Native People
    Personal Author:
    Ching, Lance K.; Gounder, Prabhu P.; Bulkow, Lisa; Spradling, Philip R.; Bruce, Michael; Negus, Susan; Snowball, Mary; McMahon, Brian J.;
    Published:
    Apr 06 2016
    Source:
    Liver Int. 36(10):1507-1515.
    Description:
    Background & Aims : Most regions of the world have <3 co-circulating hepatitis B virus (HBV) genotypes, which limits direct comparisons of hepatocellular carcinoma (HCC) risk among HBV-infected persons by genotype. We evaluated HCC incidence b...
    Public Access
    Available on:
    October 01, 2017
  3. Coming Soon
    Risk of End Stage Liver Disease, Hepatocellular Carcinoma and Liver-Related Death By Fibrosis Stage in the Hepatitis C Alaska Cohort
    Personal Author:
    Bruden, Dana JT; McMahon, Brian J.; Townshend-Bulson, Lisa; Gounder, Prabhu; Gove, Jim; Plotnik, Julia; Homan, Chriss; Hewitt, Annette; Barbour, Youssef; Spradling, Philip R.; Simons, Brenna C.; McArdle, Susan; Bruce, Michael;
    Published:
    May 22 2017
    Source:
    Hepatology. 66(1):37-45.
    Description:
    Conclusion : For prevention of HCC, LRD and ESLD in the short-term, HCV therapy should target those with more than mild fibrosis.
    Public Access
    Available on:
    July 01, 2018
  4. Coming Soon
    Hepatocellular Carcinoma Risk in Hepatitis B Virus Infected Alaska Native Children and Young Adults: Retrospective Cohort Analysis
    Personal Author:
    Gounder, Prabhu P.; Bulkow, Lisa R.; Snowball, Mary; Negus, Susan; Spradling, Philip R.; McMahon, Brian J.;
    Published:
    Aug 30 2016
    Source:
    J Pediatr. 178:206-213.
    Description:
    Objectives : To evaluate the hepatocellular carcinoma (HCC) risk in hepatitis B virus (HBV)-infected Alaska Native (AN) children and young adults. : Study design : Retrospective analysis of a population-based cohort of HBV-infected AN persons followe...
    Public Access
    Available on:
    November 01, 2017
  5. Association of Early Age at Establishment of Chronic Hepatitis B Infection with Persistent Viral Replication, Liver Cirrhosis and Hepatocellular Carcinoma: A Systematic Review
    Personal Author:
    Shimakawa, Yusuke; Yan, Hong-Jing; Tsuchiya, Naho; Bottomley, Christian; Hall, Andrew J.;
    Published:
    Jul 19 2013
    Source:
    PLoS One. 2013; 8(7).
    Description:
    Age at infection with hepatitis B virus (HBV) is a known risk factor for chronic HBV infection. However, in addition, there is some evidence that early age at infection further increases the risk of primary liver cancer beyond its association with in...
    File Type:
    Filetype[PDF - 723.14 KB]